Could a pill replace surgery for rare liver tumors?
NCT ID NCT06490757
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called baricitinib (a JAK1 inhibitor) to see if it can shrink large inflammatory liver adenomas (a rare, non-cancerous tumor) in 25 people. The goal is to reduce tumor size enough to avoid surgery. Participants will take the drug for a short time, and doctors will monitor tumor changes with MRI scans at 3 and 6 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY HEPATOCELLULAR ADENOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NAULT
RECRUITINGBobigny, 93000, France